A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT00448292. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of PRX-00023 in Patients With Major Depressive Disorder.
Study identification
- NCT ID
- NCT00448292
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Epix Pharmaceuticals, Inc.
- Industry
- Enrollment
- 330 participants
Conditions and interventions
Conditions
Interventions
- PRX-00023 Drug
- Placebo for PRX-00023 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2007
- Primary completion
- Not listed
- Completion
- Oct 31, 2007
- Last update posted
- Nov 13, 2007
2007
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vista Medical Research, Inc. | Mesa | Arizona | 85206 | — |
| Pharmacology Research Institute | Encino | California | 91316 | — |
| Pharmacology Research Institute | Los Alamitos | California | 90720 | — |
| Synergy Clinical Research Center | National City | California | 91950 | — |
| Excell Research | Oceanside | California | 92056 | — |
| Pacific Clinical Research Medical Group | Riverside | California | 92506 | — |
| AVI Clinical Research | Torrance | California | 90505 | — |
| Pacific Clinical Research Medical Group | Upland | California | 91786 | — |
| GWU Clinical Psychiatric Research Center | Washington D.C. | District of Columbia | 20037 | — |
| CNS Healthcare of Jacksonville | Jacksonville | Florida | 32216 | — |
| Atlanta Institute of Medicine and Research | Atlanta | Georgia | 30328 | — |
| Chicago Research Center, Inc. | Chicago | Illinois | 60634 | — |
| Vince and Associates Clinical Research | Overland Park | Kansas | 66212 | — |
| Brentwood Research Institute | Shreveport | Louisiana | 71101 | — |
| Piedmont Neuropsychiatry | Charlotte | North Carolina | 28216 | — |
| University of Pennsylvannia | Philadelphia | Pennsylvania | 19140 | — |
| SE Health Consultants, LLC | Charleston | South Carolina | 29407 | — |
| University of Texas - Southwestern Medical Center | Dallas | Texas | 75235 | — |
| R/D Clinical Research, Inc. | Lake Jackson | Texas | 77566 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98004 | — |
| Summit Research Network | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00448292, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2007 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00448292 live on ClinicalTrials.gov.